TP53 and cancer: The relative frequencies of selected mutations and copy-number alterations curated as potentially oncogenic in OncoKB [14] and/or as putative driver alterations in the Cancer Hotspots [15] database in the RTK/RAS/MAPK, PI3K, P53, cell cycle, and telomere maintenance pathways among the 37 F3T3-positive GBMs are presented in Fig. 3 and Additional file 1: Fig. S2.